Darla

People are coming off the fat jabs thin and unable to feel pleasure, and the mechanism behind it has a name. The reports have gone from rare to routine. Nothing tastes of anything. Nothing is worth getting up for. The hobby stopped, the sex drive went, and the friends stopped ringing because there was nothing left to ring about. The literature now lists anhedonia, emotional blunting and apathy together, on the same page. Almost every account describes it the same way. The food noise went quiet, and then everything else went quiet with it. Here is why, and it is the design of the drug rather than the dose. Natural GLP-1 survives about two minutes in your bloodstream. It fires after a meal, tells the brain the food has landed, and is gone before you have cleared the plate. The injected version lasts a week. Same receptor, same circuit, held open continuously instead of flashing once and stopping. Now look at where those receptors sit. The ventral tegmental area and the nucleus accumbens. The wanting circuit. That circuit has no food setting. It is the one system running every reinforced behaviour you own. Alcohol, nicotine, gambling, sex, novelty, ambition, the pull toward another person. Which is exactly why these drugs quietly cut drinking in people who never set out to drink less, and reduce gambling and compulsive shopping in the trial data. Rodent work found the drug flattens the phasic dopamine burst to a reward cue. The spike that means want that. Hold that spike down for a week at a time, every week, and the wanting itself goes flat. Retatrutide, the triple agonist, took 28.3 per cent of body weight off in phase 3. Around forty per cent of what comes off on these drugs is lean tissue. Stop, and the fat returns. The muscle does not. So the bill reads: a smaller body, less muscle, a payment every month for life, and the volume turned down on the machinery that makes anything feel worth doing. They measured the pounds at week eighty. Nobody asked whether anyone still looked forward to things.